HLA class I and II expression in stem cells and cells of mature central nervous system

Authors

  • L. D. Lyubych Romodanov Neurosurgery Institute, Kiev, Ukraine

DOI:

https://doi.org/10.25305/unj.126791

Keywords:

система головного комплексу гістосумісності, антигени HLA I і II класів, стовбурові клітини, клітини-попередниці, антиген-презентуючі клітини

Abstract

The overview is dedicated to the present state of the problem of MHC antigens expression in stem cells, progenitors and mature central nervous system (CNS) cells in normal and pathological conditions. The antigen-presenting potential of CNS cells is discussed.

References

Демина Т.Н., Майлян Э.А., Гюльмамедова И.Д., Гюльмамедов В.А. Современные взгляды на иммунологию гестационного процесса // Репродуктивное здоровье женщины. — 2003. — №19130. — С.43–48.

Полтавцева Р.А., Марей М.В., Дубровина И.В. и др. Развитие и дифференцировка мультипотентных нейральных клеток человека in vitro // Докл. АН. — 2001. — Т.379, №6. — С.845–849.

Хаитов Р.М., Алексеев Л.П. Физиологическая роль главного комплекса гистосовместимости человека // Иммунология. — 2001. — №3. — С.4–12.

Arpinati M., Terragna C., Chirumbolo G. et al. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade // Exp. Hematol. — 2003. — V.31, N1. — P.31–38.

Baton F., Deruyffelaere C., Chapin M. et al. Class II transactivator (CIITA) isoform expression and activity in melanoma // Melanoma Res. — 2004. — V.14, N6. — P.453–461.

Chen J.L., Guo Z.K., Xu C. et al. Mesenchymal stem cells suppress allogeneic T cell responses by secretion of TGF-beta1 // Zhongguo Shi Yan Xue Ye Xue Za Zhi. — 2002. — V.10, N4. — P.285–288.

Czeonkowska A., Kurkowska-Jastrzebska I., Czeonkowski A. et al. Immune processes in the pathogenesis of Parkinson’s disease — a potential role for microglia and nitric oxide // Med. Sci. Monit. — 2002. — V.8, N8. — P.165–177.

Draper J.S., Pigott C., Thomson J.A., Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture // J. Anat. — 2002. — V.200, N3. — P.249–258.

Drukker M., Katz G., Urbach A. et al. Characterization of the expression of MHC proteins in human embryonic stem cells // PNAS USA. — 2002. — V.99, N15. — P.9864–9869.

Ennas M.G., Cocchia D., Silvetti E. et al. Immunocompetent cell markers in human fetal astrocytes and neurons in culture // J. Neurosci. Res. — 1992. — V.32, N3. — P.424–436.

Fan C.G., Tang F.W., Zhang Q.J. et al. Characterization and neural differentiation of fetal lung mesenchymal stem cells // Cell. Transplant. — 2005. — V.14, N5. — P.311–321.

Gobin S.J., Montagne L., Van Zutphen M. et al. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions // Glia. — 2001. — V.36, N1. — P.68–77.

Gotherstrom C., Ringdon O., Tammik C. et al. Immunologic properties of human fetal mesenchymal stem cells // Am. J. Obstet. Gynecol. — 2004. — V.190, N1. — P.239–245.

Gotherstrom C., West A., Liden J. et al. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells // Haematologica. — 2005. — V.90, N8. — P.1017–1026.

Hassan-Zahraee M., Ladiwala U., Lavoie P.M. et al. Superantigen presenting capacity of human astrocytes // J. Neuroimmunol. — 2000. — V.102, N2. — P.131–136.

Hollister R.D., Xia M., McNamara M.J., Hyman B.T. Neuronal expression of class II major histocompatibility complex (HLA-DR) in 2 cases of Pick disease // Arch. Neurol. — 1997. — V.54, N3. — P.243–248.

Igura K., Zhang X., Takahashi K. et al. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta // Cytotherapy. — 2004. — V.6, N6. — P.543–553.

Jiang X.X., Zhang Y., Liu B. et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells // Blood. — 2005. — V.105, N10. — P.4120–4126.

Krampera M., Cosmi L., Angeli R. et al. Role for IFN-(gamma) in the immunomodulatory activity of human bone marrow mesenchymal stem cells // Stem cells. — 2005.

Lampson L.A. Biological significance of HLA-A,B,C expression in neuroblastoma and related cell lines // Prog. Clin. Biol. Res. — 1988. — V.271. — P.409–420.

Lampson L.A., George D.L. Interferon-mediated induction of class I MHC products in human neuronal cell lines: analysis of HLA and beta 2-m RNA, and HLA-A and HLA-B proteins and polymorphic specificities // J. Interferon Res. — 1986. — V.6, N3. — P.257–265.

Lehky T.J., Jacobson S. Induction of HLA class II in HTLV-I infected neuronal cell lines // J. Neurovirol. — 1995. — V.1, N2. — P.145–156.

Liu A., Takahashi M., Toba K. et al. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells // Hematol. Oncol. — 1999. — V.17, N4. — P.149–160.

McLaren F.H., Svendsen C.N., Van der Meide P., Joly E. Analysis of neural stem cells by flow cytometry: cellular differentiation modifies patterns of MHC expression // J. Neuroimmunol. — 2001. — V.112, N1–2. — P.35–46.

McLaurin J., Antel J.P., Yong V.W. Immune and non-immune actions of interferon-beta-1b on primary human neural cells // Mult. Scler. — 1995. — V.1, N1. — P.10–19.

Medana I., Martinic M.A., Wekerle H., Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T-lymphocytes // Am. J. Pathol. — 2001. — V.159, N3. — P.809–815.

Nagai A., Mishima S., Ishida Y. et al. Immortalized human microglial cell line: phenotypic expression // J. Neurosci. Res. — 2005. — V.81, N3. — P.342–348.

Nagai A., Nakagawa E., Hatori K. et al. Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines // Neurobiol. Dis. — 2001. — V.8, N6. — P.1057–1068.

Nagarajan U.M., Peijnenburg A., Gobin S.J. et al. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells // J. Immunol. — 2000. — V.164, N7. — P.3666–3674.

Neumann H., Wekerle H. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration // J. Neuropathol. Exp. Neurol. —1998. — V.57, N1. — P.1–9.

Niemeyer P., Seckinger A., Simank H.G. et al. Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study // Orthopade. — 2004. — V.33, N12. — P.1346–1353.

Odeberg J., Piao J.H., Samuelsson E.B. et al. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression // J. Neuroimmunol. — 2005. — V.161, N1–2. — P.1–11.

Poltavtseva R.A., Marey M.V., Aleksandrova M.A. et al. Evaluation of progenitor cell cultures from human embryons for neurotransplantation // Brain Res. Dev. Brain Res. — 2002. — V.134, N1–2. — P.149–154.

Prat A., Biernacki K., Becher B., Antel J.P. B7 expression and antigen presentation by human endothelial cells: requirement for proinflammatory cytokines // J. Neuropathol. Exp. Neurol. — 2000. — V.59, N2. — P.129–136.

Puppo F., Contini P., Ghio M. et al. Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? // Int. Immunol. — 2000. — V.12. — P.195–203.

Santambrogio L., Belyanskaya S.L., Fischer F.R. et al. Developmental plasticity of CNS microglia // PNAS USA. — 2001. — V.98, N11. — P.6295–6300.

Schmitt A.B., Brook G.A., Buss A. et al. Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen // Neuropathol. Appl. Neurobiol. — 1998. — V.24, N3. — P.167–176.

Shih D.T., Lee D.C., Chen S.C. et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue // Stem Сells. — 2005. — V.23, N7. — P.1012–1020.

Schreuder G.M., Hurley C.K., Marsh S.G. et al. HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their assotiation with serologically defined HLA-A, -B, -C, -DR, and –DQ antigens // Hum. Immunol. — 2005. — V.66, N2. — P.170–210.

Soos J.M., Morrow J., Ashley T.A. et al. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T-cells // J. Immunol. — 1998. — V.161, N11. — P.5959–5966.

Sotiropoulou P.A., Perez S.A., Salagianni M. et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells // Stem Cells. — 2005.

Van der Maesen K., Hinojoza J.R., Sobel R.A. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinaying conditions // J. Neuropathol. Exp. Neurol. — 1999. — V.58, N4. — P.346–358.

Wiendl H., Feger U., Mittelbronn M. et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity // Brain. — 2005.

Zhang L., Hong T.P., Hu J. et al. Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells // World J. Gastroenterol. — 2005. — V.11, N19. — P.2906–2911.

Zhou Z., Jiang E.L., Wang M. et al. Comparative study on various subpopulations in mesenchymal stem cells of adult bone marrow // Zhongguo Shi Yan Xue Ye Xue Za Zhi. — 2005. — V.13, N1. — P.54–58.

How to Cite

Lyubych, L. D. (2006). HLA class I and II expression in stem cells and cells of mature central nervous system. Ukrainian Neurosurgical Journal, (2), 4–9. https://doi.org/10.25305/unj.126791

Issue

Section

Review articles